Shares of Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) fell 0.5% during trading on Tuesday . The company traded as low as $18.54 and last traded at $18.65. Approximately 3,519 shares changed hands during trading, a decline of 83% from the average session volume of 20,556 shares. The stock had previously closed at $18.75.
Fortress Biotech Stock Performance
The company’s 50 day moving average price is $18.89 and its two-hundred day moving average price is $16.84.
About Fortress Biotech
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
Read More
- Five stocks we like better than Fortress Biotech
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
